OCTA and Polypoidal Choroidal Vasculopathy

Choroid and Choriocapillary Changes in Polypoidal Choroidal Vasculopathy After Intravitreal Anti-VEGF Therapy

To investigate the structural and vascular features of choroid in patients affected by PCV after Ranibizumab intravitreal injection.

Polypoidal choroidal vasculopathy represents a distinct form of choroidal neovascularization.

The study investigated the changes in choroidal vascular network after anti-VEGF therapy using optical coherence tomography angiography, a novel and non invasive diagnostic technique that allows to better understand the pathophysiologic mechanism of this neovascularization.

Inclusion Criteria:

• age older than 60 years
• diagnosis of polypoidal choroidal vasculopathy
• absence of previous ocular surgery, congenital eye disease, high myopia (>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
• absence of significant lens opacities, low-quality OCT-A images.

Exclusion Criteria:

• age older than 80 years
• absence of diagnosis of polypoidal choroidal vasculopathy
• presence of previous ocular surgery, congenital eye disease, high myopia (>6 dioptres), actual or previous diagnosis of glaucoma, optic disc anomaly, macular or vitreoretinal diseases.
• presence of significant lens opacities, low-quality OCT-A images.